Acorda Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
23 Jun 2023	Form 3: Burns Thomas M., Director No securities owned
05 Jan 2022	Form 3: Varian John, Director No securities owned
09 Nov 2021	Form 3: Gesser Michael A, Chief Financial Officer No securities owned
09 Nov 2021	Form 3: Belloff Neil S., General Counsel No securities owned
20 Sep 2021	Form 3: Clem Kerry M, Chief Commercial Officer Holds 11,594 shares of Common Stock
22 Mar 2021	Form 3: Morales Robert, Interim PAO & PFO Holds 4,872 shares of Common Stock
08 Aug 2017	Form 3: Scopia Capital Management Lp, 10% owner and 3 others Holds 7,708,527 shares of Common Stock
22 Feb 2017	Form 3: Strader Catherine D., Director No securities owned
06 Jul 2016	Form 3: Blank Burkhard, Chief Medical Officer No securities owned
02 Jul 2015	Form 3: Batycky Richard P., Chief Tech. Off. & Site Head Holds 47,979 shares of Common Stock
15 May 2014	Form 3: Hindman Andrew A., Chief Business Dev. Officer No securities owned
09 Oct 2013	Form 3: Rogers Michael W, Chief Financial Officer No securities owned
19 Dec 2011	Form 3: Carrazana Enrique J., Chief Medical Officer Holds 25,000 shares of Common Stock
21 Apr 2011	Form 3: Jensen Peder, Director Holds 0 shares of No securities are beneficially owned
02 Feb 2010	Form 3: Sabella Lauren M, Exec. VP-Commercial Dvlpmnt Holds 25,000 shares of Common Stock
12 Feb 2009	Form 3: Wessel Thomas, Chief Medical Officer Holds 25,000 shares of Common Stock
26 Nov 2008	Form 3: Kelley John P, Director Holds 0 shares of No securities are beneficially owned.
05 Feb 2007	Form 3: Smith Ian F, Director Holds 0 shares of No securities are beneficially owned.
10 Jan 2007	Form 3: Greene Barry E, Director Holds 0 shares of No securities are beneficially owned.
05 Oct 2006	Form 3: Ridgeback Capital Investments Ltd., 10% owner and 2 others Holds 3,328,762 shares of Common Stock

Comments